Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Next Generation Sequencing Analysis of OX40hi Treg and OX40lo Treg cells from mouse tumors and spleens

ABSTRACT: Next Generation Sequencing Analysis of OX40hi Treg and OX40lo Treg cells from mouse tumors and spleens

PROVIDER: PRJNA791942 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR17322360_1.fastq.gz	Fastqsanger.gz
	SRR17322360_2.fastq.gz	Fastqsanger.gz
	SRR17322361_1.fastq.gz	Fastqsanger.gz
	SRR17322361_2.fastq.gz	Fastqsanger.gz
	SRR17322362_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 56

Similar Datasets

Next Generation Sequencing Analysis of OX40hi Treg and OX40lo Treg cells from mouse tumors and spleens

Project description:Based on RNA-seq technology, we studies gene expression profiles in Treg cells isolated from mouse tumors and spleens. We identified differential gene expressions comparing OX40hi Treg with OX40lo Treg cells from tumors and spleens. The difference of Trges in tumors and spleens were also identified.

2022-12-21 | GSE192563 | GEO

Next Generation Sequencing Facilitates Quantitative Analysis of adipose tissue Treg and LN Treg Transcriptomes

Project description:Next Generation Sequencing Facilitates Quantitative Analysis of adipose tissue Treg and LN Treg Transcriptomes

| PRJNA513260 | ENA

Directed natural evolution generates a next-generation oncolytic virus with a high potency and safety profile for multiple solid tumors

Project description:Mass spectrometry raw data for submitting manuscript entitled "Directed natural evolution generates a next-generation oncolytic virus with a high potency and safety profile for multiple solid tumors" to Nature Communications.

2023-05-22 | PXD037429 | Pride

MiRNA Profiling of Colorectal Tumors by Next Generation Sequencing

Project description:MiRNA Profiling of Colorectal Tumors by Next Generation Sequencing

| PRJNA673192 | ENA

Gene expression profile of effector Treg cells isolated from spleens and tumors of tumor-bearing mice

Project description:Gene expression profile of effector Treg cells isolated from spleens and tumors of tumor-bearing mice

| PRJNA737439 | ENA

Next Generation Sequencing of Wild Type and Nsd2 Treg cells conditional knock out Treg cells Transcriptomes

Project description:Next Generation Sequencing of Wild Type and Nsd2 Treg cells conditional knock out Treg cells Transcriptomes

| PRJNA744050 | ENA

Next-generation sequencing of tumors with oral squamous cell carcinoma

Project description:Next-generation sequencing of tumors with oral squamous cell carcinoma

| PRJNA735400 | ENA

Next Generation Sequencing Analysis of mouse tumors treated with rMVA

Project description:Next Generation Sequencing Analysis of mouse tumors treated with rMVA

| PRJNA779078 | ENA

TCR repertoire analysis by Next-generation sequencing of mouse CD8+ T cells in spleen or tumor

Project description:We have reported that intra-tumoral treatment with 1V270, a phospholipid-conjugated TLR7 agonist,induces local expansion an systemic dispersion of oligoclonal tumor-specific T cells by TCR repertoire analysis using next generation RNAseq methodology. Here, we examined whether systemic 1V270 therapy also induced oligoclonal expansion of tumor-specific T cells. Two groups of BALB/c mice (n=4/group) were i.p. treated with 1V270,a phospholipid-conjugated TLR7 agonist. One cohort of mice was i.v. injected with 4T1-GLF cells (2×104) on day 0. Another cohort did not receive i.v. tumor injection (no tumor-exposed mice). 4T1 cells were orthotopically inoculated on day 21. To examine clonal specificity of tumor-specific T cells, CD8+ cells were isolated from the spleens and the tumor infiltrating lymphocytes of secondarily challenged tumors after initial 1V270 therapy. The TCR repertoires were assessed by next generation RNA sequencing of both TCRαand TCR β genes.

2018-07-31 | E-MTAB-6566 | biostudies-arrayexpress

Expression data of Naïve Treg and Tumor associated Treg cells

Project description:Naïve Treg cells were purified from the resting spleens of FoxP3-GFP knock-in mice made in the 129/SvJ strain. Ascites Treg cells were tumor-associated FoxP3-GFP+ cells sorted from the tumor ascites of 129/SvJ mice IP-injected with 1 x 10e6 RMAS cells 5 days earlier; Spleen-T Treg cells were purified from the spleens of the same tumor-bearing mice. Keywords: in vivo samples Affymetrix MOE430v2 arrays were used to perform gene expression studies. The purity of the sorted Treg cells is >99%.

2008-10-31 | E-GEOD-13409 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data